提高单域催化抗体的热稳定性和可溶性
Yunhang Cui1, Xuchen Zhou2,3,4,5, Sainan Li2,3,4,5
1College of Life Sciences, Qingdao Agricultural University, No. 700 Changcheng Road, Chengyang District, Qingdao 266109, China.
Protein engineering, design & selection : PEDS
|February 17, 2025
概括
研究人员增强了催化抗体光链 (UA15-L),以提高稳定性和可溶性. 这种工程蛋白有效地向Helicobacter pylori尿酶,显示了对抗细菌感染的治疗应用的潜力.
科学领域:
- 生物化学 生物化学
- 蛋白质工程是指蛋白质工程.
- 免疫学 免疫学 免疫学
背景情况:
- 催化抗体通过降解抗原来提供治疗潜力.
- UA15-L抗体的轻链分裂了Helicobacter pylori尿酶,抑制了细菌的传播.
- UA15-L的可变域表现出较差的热稳定性和可溶性,限制了其应用.
研究的目的:
- 为了提高UA15-L变量域的稳定性和可溶性.
- 为治疗应用设计改进的蛋白质变体.
- 研究蛋白质稳定和可溶性增强的方法.
主要方法:
- 利用分子动力学模拟来识别蛋白质展开的热点.
- 在展开的热点处引入二硫化物键,以增加蛋白质的稳定性.
- 采用计算方法在蛋白质表面引入极性或带电残留物,提高溶解度.
- 结合了蛋白质工程的计算和实验方法.
主要成果:
- 开发了UA15-L可变域变体,显著改善了热稳定性和溶解性.
- 在高温下达到增强的蛋白质表达和活性.
- 通过引入二硫化物键和通过表面残留物修饰提高溶解度,通过表面残留物修饰证明了成功的稳定.
- 确定了有前途的变体,以进一步发展催化活性和特异性.
结论:
- 结合计算和实验策略,有效地提高了蛋白质的稳定性和可溶性.
- 工程 UA15-L 变种显示出对治疗 H. pylori 的治疗应用的潜力.
- 进一步的工程可以优化针对性治疗的催化活性和特异性.
相关概念视频
01:31Hybridoma Technology
14.0K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
14.0K
01:26Antibody Actions
1.0K
Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
1.0K
01:10Antibody Structure
58.8K
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
58.8K